Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002076369-25-000001
Filing Date
2025-07-15
Accepted
2025-07-14 17:58:55
Documents
1
Effectiveness Date
2025-07-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5611
  Complete submission text file 0002076369-25-000001.txt   6724
Mailing Address 999 THIRD AVENUE SUITE 3900 SEATTLE WA 98104-4076
Business Address 251 LITTLE FALLS DRIVE WILMINGTON DE 19808 866-403-5272
DSIpharma, Inc. (Filer) CIK: 0002076369 (see all company filings)

EIN.: 392901038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-551710 | Film No.: 251122609